Point-of-Care INR Testing
Cross-source consensus on Point-of-Care INR Testing from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Benefits
Highlighted claims
- Patients were excluded from enrolment if the POCT-to-laboratory INR difference exceeded 0.3 units, ensuring device accuracy. — Evaluation of a pharmacist-led patient-self-testing model for warfarin management in patients undergoing mechanical heart valve replacement in China: a multicentre, open-label, randomised, controlled trial
- PST patients attended outpatient clinics every 3–6 months for a laboratory INR cross-check to provide external quality assessment of the POCT device. — Evaluation of a pharmacist-led patient-self-testing model for warfarin management in patients undergoing mechanical heart valve replacement in China: a multicentre, open-label, randomised, controlled trial
- POCT devices and pharmacist guidance were provided free of charge to PST patients, with test strips subsidised. — Evaluation of a pharmacist-led patient-self-testing model for warfarin management in patients undergoing mechanical heart valve replacement in China: a multicentre, open-label, randomised, controlled trial
- Performing 41 INR tests per person-year versus 8 in usual care enables earlier detection of out-of-range values and faster dose correction. — Evaluation of a pharmacist-led patient-self-testing model for warfarin management in patients undergoing mechanical heart valve replacement in China: a multicentre, open-label, randomised, controlled trial